QR-1123 | Interleukin Related interleukin-related.com

Product Name :
QR-1123

Search keywords :
Rhodopsin

drugId :
null

Target Vo:
Rhodopsin

Target Vo Short Name :
RHO

Moa_Name:
Rhodopsin P23H mutant protein expression inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Ionis Pharmaceuticals Inc

Active Company_Name :
Proqr Therapeutics

Active Indication_Name:
Retinitis Pigmentosa

In Active Indication_Name:
Eye Diseases

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
LAMP2a Antibody
p53 Antibody (YA250)
Ubiquitin Antibody: Ubiquitin Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 26 kDa, targeting to Ubiquitin. It can be used for WB,IHC-P,ICC/IF,FC assays with tag free, in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts